Pharmacy
News, opinions and meeting coverage in pharmacy.
β Paul Offit, MD, talks about the flu, RSV, and COVID vaccines for the 2024-2025 season
Latest in Pharmacy
This new surge is different, WHO leader says
Initial trials were not powered to assess efficacy against RSV-associated hospitalization
Unlike the mRNA vaccines, protein-based vaccine targets JN.1 strain
Also in TTHealthWatch: myocarditis after COVID vaccination
Unlike the mRNA vaccines, protein-based vaccine targets JN.1 strain
Also in TTHealthWatch: myocarditis after COVID vaccination
More in Pharmacy
As both candidates battle Big Pharma, the industry's financial support sways toward Democrats
Evolution of postvaccine myocarditis tracked for 18 months in cohort study
Health news and commentary gathered by ΒιΆΉ΄«Γ½ staff
Agency predicts the respiratory virus season will be similar to last year
And being up-to-date on HPV vaccination by age 13 fell among kids born in 2010
mRNA vaccines for 2024-2025 season will target the KP.2 subvariant
Risks for depression and serious mental illness highest among unvaccinated people
Clinicians not specializing in ID could benefit from more PrEP training, researchers say
Health news and commentary gathered by ΒιΆΉ΄«Γ½ staff
Only patients who had two or more relapses in the previous 2 years had an increased risk
From abortion to drug prices to gun control, here's how the presidential candidates stack up
"We need to do more," says agency's chief medical officer
"We've seen data showing that vaccination rates across the board globally have dropped"
